Acrivon Competitors and Similar CompaniesClear all
CARsgen Therapeutics's competitors and similar companies include Numab and OncoTherapy Science.
 CARsgen Therapeutics CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment. |  OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics. | ||
Founding Date | Founding Date 2014 | Founding Date 2011 | Founding Date 2001 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Shanghai, CN HQ Beijing, CN Shanghai, CN Shanghai, CN Bellaire, US | Locations Wädenswil, CH HQ | Locations Kawasaki, JP HQ |
Employees | Employees 100 | Employees 681% decrease | Employees 54 |
Funding | |||
Latest funding round | Latest funding round $ 186m (over 5 years ago) | Latest funding round $ 110m (about 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 276m | Total funding raised $ 132.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Numab
HQ
Wädenswil, CH
Employees
68↓ 1% decrease
Numab Therapeutics is an oncology-focused biopharmaceutical company.
View companyOncoTherapy Science
HQ
Kawasaki, JP
Employees
54
OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
View company